Kit C. B. Roes

4.5k total citations · 1 hit paper
143 papers, 2.9k citations indexed

About

Kit C. B. Roes is a scholar working on Statistics and Probability, Economics and Econometrics and Statistics, Probability and Uncertainty. According to data from OpenAlex, Kit C. B. Roes has authored 143 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Statistics and Probability, 44 papers in Economics and Econometrics and 24 papers in Statistics, Probability and Uncertainty. Recurrent topics in Kit C. B. Roes's work include Statistical Methods in Clinical Trials (43 papers), Health Systems, Economic Evaluations, Quality of Life (42 papers) and Advanced Causal Inference Techniques (22 papers). Kit C. B. Roes is often cited by papers focused on Statistical Methods in Clinical Trials (43 papers), Health Systems, Economic Evaluations, Quality of Life (42 papers) and Advanced Causal Inference Techniques (22 papers). Kit C. B. Roes collaborates with scholars based in Netherlands, United States and United Kingdom. Kit C. B. Roes's co-authors include Rolf H. H. Groenwold, Arno W. Hoes, Olaf H. Klungel, Anthonius de Boer, Karel G.M. Moons, A. Rogier T. Donders, Frank E. Harrell, Ronald J. M. M. Does, Ingeborg van der Tweel and Stavros Nikolakopoulos and has published in prestigious journals such as JAMA, Circulation and Nature Communications.

In The Last Decade

Kit C. B. Roes

134 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial

2023 77 citations Sander van Doorn, Melchior C. Nierman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kit C. B. Roes Netherlands	28	645	529	377	335	273	143	2.9k
Andrew P. Grieve United Kingdom	25	780 1.2×	376 0.7×	198 0.5×	337 1.0×	170 0.6×	81	2.7k
Shirley Wang United States	32	676 1.0×	919 1.7×	198 0.5×	533 1.6×	264 1.0×	147	4.1k
G. Lu United Kingdom	10	645 1.0×	559 1.1×	781 2.1×	397 1.2×	323 1.2×	13	4.6k
Ying Kuen Cheung United States	28	1.1k 1.7×	413 0.8×	119 0.3×	257 0.8×	191 0.7×	114	2.5k
Gert van Valkenhoef Netherlands	20	319 0.5×	314 0.6×	325 0.9×	366 1.1×	147 0.5×	33	2.6k
Adrian Mander United Kingdom	31	792 1.2×	375 0.7×	220 0.6×	132 0.4×	169 0.6×	115	4.3k
Stéphane Héritier Australia	33	512 0.8×	219 0.4×	187 0.5×	376 1.1×	273 1.0×	133	3.6k
James Wason United Kingdom	27	1.0k 1.6×	494 0.9×	254 0.7×	82 0.2×	138 0.5×	160	2.8k
Rachael Fleurence United States	24	218 0.3×	692 1.3×	247 0.7×	249 0.7×	140 0.5×	50	3.2k
Werner Brannath Austria	35	1.7k 2.7×	538 1.0×	241 0.6×	91 0.3×	303 1.1×	119	3.7k

Countries citing papers authored by Kit C. B. Roes

Since Specialization

Citations

This map shows the geographic impact of Kit C. B. Roes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kit C. B. Roes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kit C. B. Roes more than expected).

Fields of papers citing papers by Kit C. B. Roes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kit C. B. Roes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kit C. B. Roes. The network helps show where Kit C. B. Roes may publish in the future.

Co-authorship network of co-authors of Kit C. B. Roes

This figure shows the co-authorship network connecting the top 25 collaborators of Kit C. B. Roes. A scholar is included among the top collaborators of Kit C. B. Roes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kit C. B. Roes. Kit C. B. Roes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arlett, Peter, Patrice Verpillat, Paolo Foggi, et al.. (2025). Clinical Evidence 2030. Clinical Pharmacology & Therapeutics. 117(4). 884–886. 5 indexed citations

Arlett, Peter, Kit C. B. Roes, Flora T. Musuamba, et al.. (2024). Artificial Intelligence in European Medicines Regulation: From Vision to Action. Harnessing the Capabilities of Artificial Intelligence for the Benefit of Public and Animal Health. Clinical Pharmacology & Therapeutics. 117(2). 335–336. 2 indexed citations

Deforth, Manja, et al.. (2023). Combining evidence from clinical trials in conditional or accelerated approval. Pharmaceutical Statistics. 22(4). 707–720. 2 indexed citations

Eijk, Ruben P. A. van, Leonard H. van den Berg, Kit C. B. Roes, et al.. (2023). Hybrid Controlled Clinical Trials Using Concurrent Registries in Amyotrophic Lateral Sclerosis: A Feasibility Study. Clinical Pharmacology & Therapeutics. 114(4). 883–892. 2 indexed citations

Brink, Wim van den, et al.. (2023). Ethnic differences in response to atypical antipsychotics in patients with schizophrenia: individual patient data meta-analysis of randomised placebo-controlled registration trials submitted to the Dutch Medicines Evaluation Board. BJPsych Open. 9(2). e45–e45.

Ramjith, Jordache, Andreas Bender, Kit C. B. Roes, & Marianne A. Jonker. (2022). Recurrent events analysis with piece-wise exponential additive mixed models. Statistical Modelling. 24(3). 266–287. 5 indexed citations

Wohlfarth, Tamar, Christine C. Gispen‐de Wied, Kit C. B. Roes, et al.. (2022). Gender differences in the response to antipsychotic medication in patients with schizophrenia: An individual patient data meta-analysis of placebo-controlled studies. Psychiatry Research. 320. 114997–114997. 15 indexed citations

Raafs, Anne G., Jacqueline L Vos, Michiel T.H.M. Henkens, et al.. (2022). Left Atrial Strain Has Superior Prognostic Value to Ventricular Function and Delayed-Enhancement in Dilated Cardiomyopathy. JACC. Cardiovascular imaging. 15(6). 1015–1026. 52 indexed citations

Schrijvers, A.J.P., et al.. (2021). Medical Specialists' Perspectives on the Influence of Electronic Medical Record Use on the Quality of Hospital Care: Semistructured Interview Study. JMIR Human Factors. 8(4). e27671–e27671. 6 indexed citations

10.

Lassila, Toni, et al.. (2021). In-silico trial of intracranial flow diverters replicates and expands insights from conventional clinical trials. Nature Communications. 12(1). 3861–3861. 48 indexed citations

11.

Öner, F. Cumhur, et al.. (2021). The SNAP Trial: 2-Year Results of a Double-Blind Multicenter Randomized Controlled Trial of a Silicon Nitride Versus a PEEK Cage in Patients After Lumbar Fusion Surgery. Global Spine Journal. 12(8). 1687–1695. 10 indexed citations

12.

Vreman, Rick A., Svetlana V. Belitser, Anke M. Hövels, et al.. (2020). Efficacy gap between phase II and subsequent phase III studies in oncology. British Journal of Clinical Pharmacology. 86(7). 1306–1313. 10 indexed citations

13.

Pétavy, Frank, et al.. (2019). Beyond “Intent‐to‐treat” and “Per protocol”: Improving assessment of treatment effects in clinical trials through the specification of an estimand. British Journal of Clinical Pharmacology. 86(7). 1235–1239. 14 indexed citations

14.

Doorn, Sander van, Arno W. Hoes, Melchior C. Nierman, et al.. (2019). Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial. BMJ Open. 9(12). e032488–e032488. 11 indexed citations

15.

Andel, Judith van, Constantin Ungureanu, Johan Arends, et al.. (2017). Multimodal, automated detection of nocturnal motor seizures at home: Is a reliable seizure detector feasible?. Epilepsia Open. 2(4). 424–431. 47 indexed citations

16.

Bruijne, Martine C. de, Peter Kemper, Maria M.W. Koopman, et al.. (2017). Validation of multisource electronic health record data: an application to blood transfusion data. BMC Medical Informatics and Decision Making. 17(1). 107–107. 10 indexed citations

17.

Zegers, Marieke, Gijs Hesselink, Kit C. B. Roes, Wytske W. Geense, & Hub Wollersheim. (2015). [A proactive approach to risks: from responding tot leading].. PubMed. 159. A8940–A8940. 1 indexed citations

18.

Ng, Chong Guan, Marco P. Boks, Kit C. B. Roes, et al.. (2014). Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: A four-week, randomized, double-blinded, placebo-controlled study. European Neuropsychopharmacology. 24(4). 491–498. 37 indexed citations

19.

Schmidt, Amand F., Rolf H. H. Groenwold, Johannes J. M. van Delden, et al.. (2014). Justification of exclusion criteria was underreported in a review of cardiovascular trials. Journal of Clinical Epidemiology. 67(6). 635–644. 22 indexed citations

20.

Siregar, Sabrina, Kit C. B. Roes, Albert H.M. van Straten, et al.. (2013). Statistical Methods to Monitor Risk Factors in a Clinical Database. Circulation Cardiovascular Quality and Outcomes. 6(1). 110–118. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact